Both in Pharmaceuticals
Nexentis Technologies vs Lakewood-Amedex Biotherapeutics
Over the past year NXTS returned −65.7% and LABT returned −91.4%; their daily moves had a correlation of 0.23.
NXTS −65.7% LABT −91.4%Growth of $1, one year, split-adjusted
| Metric | NXTS | LABT |
|---|---|---|
| Price | $0.5550 | $0.1914 |
| Market cap | $806.6K | $453.6K |
| Today | −2.46% | −1.85% |
| 1 month | −60.1% | −77.9% |
| 6 months | — | — |
| Year to date | — | — |
| 1 year | — | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $8.5M | $4.6M |
| Dividend yield | — | — |
| Volatility (60d) | — | — |
| Short % of float | 2.5% | 1.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).